Lantu Gou
State Key Laboratory Of Biotherapy/Collaborative Innovation Center For Biotherapy
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
FTL008.16, a 5T4-Conditional 4-1BB bispecific antibody, potently enhances antitumor immunity via tumor-directed t-cell activation.
Journal: Oncoimmunology
Published: June 10, 2026
Dual-targeting LILRB3/LILRB4 CAR-T cells for the treatment of monocytic acute myeloid leukemia.
Journal: Biochemical pharmacology
Published: March 10, 2026
Discovery of Novel 4,5-Dihydropyrrolo[3,4-c]pyrazol-6(2H)-one-Based Tubulin Inhibitors Targeting Colchicine Binding Site with Potent Anti-Ovarian Cancer Activity.
Journal: Journal of medicinal chemistry
Published: September 20, 2025
Metabolic Profiling of Canertinib: A Comprehensive Cross-Species Investigation Using Advanced UPLC-MS/MS and LC-Orbitrap-HRMS Techniques.
Journal: Biomedical chromatography : BMC
Published: May 20, 2025
Discovery of STING antagonists targeting cGAS-STING pathway to alleviate IMQ-induced psoriasis-like dermatitis.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 27, 2024
Design, synthesis, and antitumor evaluation of quinazoline-4-tetrahydroquinoline chemotypes as novel tubulin polymerization inhibitors targeting the colchicine site.
Journal: European journal of medicinal chemistry
Published: October 16, 2024
Non-IL-2-blocking anti-CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti-CTLA-4 therapy.
Journal: International journal of cancer
Published: May 23, 2023
Antibody-drug conjugates: Recent advances in payloads.
Journal: Acta pharmaceutica Sinica. B
Published: March 09, 2023
FTL004, an anti-CD38 mAb with negligible RBC binding and enhanced pro-apoptotic activity, is a novel candidate for treatments of multiple myeloma and non-Hodgkin lymphoma.
Journal: Journal of hematology & oncology
Published: October 24, 2022
Design, Synthesis, and Bioevaluation of a Novel Hybrid Molecular Pyrrolobenzodiazepine-Anthracenecarboxyimide as a Payload for Antibody-Drug Conjugate.
Journal: Journal of medicinal chemistry
Published: August 19, 2022
Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma.
Journal: Frontiers in cell and developmental biology
Published: April 01, 2021
Last Updated: 09/26/2026